JPRN-UMIN000025351已完成未知
Phase 1 clinical trial on the safety and efficacy of the negative-balance isolated pelvic perfusion (NIPP) for pelvic malignancy (uterine cervical cancer) - NIPP phase 1
ippon medical school hospital0 个研究点目标入组 27 人开始时间: 2017年1月5日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 27
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Initial conventional therapy was not performed although indicated. 2) No measurable lesion according to RECIST ver 1.1 3) History of severe allergic reaction to iodine contrast media or platinum derivatives. 4) Impossible to catheterize due to hostile vascular anatomy 5) Contraindication to general anesthesia 6) History of heparin-induced thrombocytopenia 7) Presence of uncontrolled multiple neoplasm 8) Interstitial pneumonitis, pulmonary fibrosis, advanced emphysema, uncontrolled diabetes mellitus, uncontrolled hypertension, severe cardiac disease (heart failure, myocardial infarction, angina pectoris, etc...) with marked ECG abnormality, persistent adverse events (CTCAE ver 4.0 Grade 3 or worse) 9) Contraindication to drugs used in this study 10) Patients whom chief researcher or associate researcher judges unsuitable for this study
研究者
相似试验
已完成
1 期
Phase 1 study to evaluate the safety and efficacy of jyuzentaihoto in infantile anal fistulainfantile anal fistulaJPRN-UMIN000021336Kanazawa University20
未知
1 期
A Phase I clinical trial to investigate the safety and tolerability of NK105 when co-administered with carboplatin once per week to Japanese patients with advanced solid cancers.Advanced solid cancersJPRN-jRCT2080223202ippon Kayaku Co., Ltd.18
招募中
不适用
A Study to Evaluate Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Tripegfilgrastim in Pediatric Solid Tumor/Lymphoma PatientsNeoplasmsKCT0002244Dong-A ST32
已完成
1 期
Phase I clinical trial to evaluate safety, pharmacokinetics and immunomodulatory activity of the capsule formulation of the standardized extract of Atractylodes lanceaone.Atractylodes lanceaPharmacokineticsPhase I clinical trialSafetyImmunomodulatory activityTCTR20201020001ational Research Council of Thailand48
尚未招募
1 期
CIGB-Mambisa/Abdala in convalescentsCOVID-19 ConvalescenceCOVID-19SARS-CoV2Coronavirus InfectionsSARS VirusCoronaviridae InfectionsBetacoronavirusRPCEC00000382Center for Genetic Engineering and Biotechnology (CIGB)120